Conor Kilroy's most recent trade in Aura Biosciences Inc was a trade of 7,162 Common Stock done at an average price of $5.5 . Disclosure was reported to the exchange on April 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aura Biosciences Inc | Conor Kilroy | See Remarks | Sale of securities on an exchange or to another person at price $ 5.49 per share. | 16 Apr 2025 | 7,162 | 179,313 | - | 5.5 | 39,319 | Common Stock |
| Aura Biosciences Inc | Conor Kilroy | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 90,475 | 186,475 | - | 0 | Common Stock | |
| Aura Biosciences Inc | Conor Kilroy | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 59,525 | 59,525 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Conor Kilroy | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 144,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Conor Kilroy | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 96,000 | 96,000 | - | 0 | Common Stock | |
| Ironwood Pharmaceuticals Inc | Conor Kilroy | SVP, GC & Secretary | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 2,268 | 124,184 (0%) | 0% | 9.1 | 20,661 | Class A Common Stock |
| Ironwood Pharmaceuticals Inc | Conor Kilroy | SVP, GC & Secretary | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 1,848 | 122,336 (0%) | 0% | 9.1 | 16,835 | Class A Common Stock |
| Ironwood Pharmaceuticals Inc | Conor Kilroy | SVP, GC & Secretary | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 1,474 | 126,452 (0%) | 0% | 9.1 | 13,428 | Class A Common Stock |
| Ironwood Pharmaceuticals Inc | Conor Kilroy | SVP, GC & Secretary | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 1,399 | 127,926 (0%) | 0% | 9.1 | 12,745 | Class A Common Stock |
| Ironwood Pharmaceuticals Inc | Conor Kilroy | SVP, GC & Secretary | Sale of securities on an exchange or to another person at price $ 10.92 per share. | 09 Nov 2020 | 599 | 129,070 (0%) | 0% | 10.9 | 6,541 | Class A Common Stock |
| Ironwood Pharmaceuticals Inc | Conor Kilroy | SVP, GC & Secretary | Sale of securities on an exchange or to another person at price $ 10.92 per share. | 09 Nov 2020 | 237 | 128,833 (0%) | 0% | 10.9 | 2,588 | Class A Common Stock |